Inhibition of contact sensitivity by farnesylthiosalicylic acid-amide, a potential rap1 inhibitor

Journal of Investigative Dermatology

Volumn 131, Issue 10, 2011, Pages 2040-2048

  Mor, Adam ^a,b   Haklai, Roni ^b   Ben Moshe, Ofer ^b   Mekori, Yoseph A ^b   Kloog, Yoel ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

RAP1 PROTEIN; RAS PROTEIN; SALIRASIB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTACT SENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA;

EID: 80052837784     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.152     Document Type: Article

References (32)

1. Abram CL, Lowell CA (2009) Leukocyte adhesion deficiency syndrome: a controversy solved. Immunol Cell Biol 87:440-2
2. Barkan B, Starinsky S, Friedman E et al. (2006) The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1. Clin Cancer Res 12:5533-42 (Pubitemid 44497271)
3. Bergstresser PR (1989) Contact allergic dermatitis. Arch Dermatol 125: 276-9
4. Bivona TG, Quatela SE, Bodemann BO et al. (2006) PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 21:481-93 (Pubitemid 43228004)
5. Bivona TG, Philips MR (2005) Analysis of Ras and Rap activation in living cells using fluorescent Ras binding domains. Methods 37:138-45 (Pubitemid 41587422)
6. Bivona TG, Wiener HH, Ahearn IM et al. (2004) Rap1 up-regulation and activation on plasma membrane regulates T cell adhesion. J Cell Biol 164:461-70 (Pubitemid 38174773)
7. Bryce PJ, Miller ML, Miyajima I et al. (2004) Immune sensitization in the skin is by antigen-independent effects of IgE. Immunity 20:381-92 (Pubitemid 38482117)
8. Carey KD, Dillon TJ, Schmitt JM et al. (2000) CD28 and the tyrosine kinase Lck stimulate mitogen activated protein kinase activity in T cells via inhibition of the small G protein Rap1. Mol Cell Biol 20:8409-19
9. Carlsen BC, Andersen KE, Menné T et al. (2008) Patients with multiple contact allergies: a review. Contact Dermatitis 58:1-8 (Pubitemid 350264755)
10. Claman H, Jaffee BD (1983) Desensitization of contact allergy to DNFB in mice. J Immunol 131:2682-6
11. Dillon TJ, Carey KD, Wetzel SA et al. (2005) Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4. Mol Cell Biol 25:4117-28 (Pubitemid 40617658)
12. Elad G, Paz A, Haklai R et al. (1999) Targeting of K-Ras 4B by S-trans, trans-farnesyl thiosalicylic acid. Biochim Biophys Acta 1452:228-42
13. George J, Sack J, Barshack I et al. (2004) Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor. Arterioscler Thromb Vasc Biol 24:363-8 (Pubitemid 38197591)
14. Goldberg L, Kloog Y (2006) A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration. Cancer Res 66:11709-17 (Pubitemid 46094183)
15. Goldberg L, Ocherashvilli A, Daniels D et al. (2008) Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats. Mol Cancer Ther 7:3609-16
16. Goldberg L, Haklai R, Bauer V et al. (2009) New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesyl-thiosalicylamide inhibits tumor growth in nude mice models. J Med Chem 52:197-205
17. Haklai R, Elad-Sfadia G, Egozi Y et al. (2008) Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice. Cancer Chemother Pharmacol 61:89-96 (Pubitemid 47512630)
18. Jansen B, Schlagbauer-Wadl H, Kahr H et al. (1999) Novel Ras antagonist blocks human melanoma growth. Proc Natl Acad Sci 96:14019-24
19. Kafri M, Kloog Y, Korczyn AD et al. (2005) Inhibition of Ras attenuates the course of experimental autoimmune neuritis. J Neuroimmunol 168:46-55 (Pubitemid 41398186)
20. Katzav A, Kloog Y, Korczyn AD et al. (2001) Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin Exp Immunol 126:570-7 (Pubitemid 34008734)
21. Marom M, Haklai R, Ben-Baruch G et al. (1995) Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid. J Biol Chem 270:22263-70
22. Mor A, Dustin ML, Philips MR (2007a) Small GTPases and LFA-1 reciprocally modulate adhesion and signaling. Immunol Rev 218:114-25 (Pubitemid 47052308)
23. Mor A, Campi G, Du G et al. (2007b) The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospho-lipase D2. Nat Cell Biol 9:713-9 (Pubitemid 47214735)
24. Mor A, Wynne JP, Ahearn IM et al. (2009) Phospholipase D1 regulates lymphocyte adhesion via upregulation of Rap1 at the plasma membrane. Mol Cell Biol 29:3297-306
25. Pando R, Barshack I, Raz A et al. (2010) The Ras antagonist farnesylthiosa-licylic acid ameliorates experimental myocarditis in the rat. Cardiovasc Pathol 19:94-101
26. Pando R, Cheporko Y, Haklai R et al. (2009) Ras inhibition attenuates myocardial ischemia-reperfusion injury. Biochem Pharmacol 77: 1593-601
27. Scheele JS, Marks RE, Boss GR (2007) Signaling by small GTP in the immune system. Immunol Rev 218:92-101 (Pubitemid 47052300)
28. Thyssen JP, Linneberg A, Menné T et al. (2007) The epidemiology of contact allergy in the general population-prevalence and main findings. Contact Dermatitis 57:287-99 (Pubitemid 47568789)
29. Weisz B, Giehl K, Gana-Weisz M et al. (1999) A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice. Oncogene 18:2579-88 (Pubitemid 29216680)
30. Zhu K, Hamilton AD, Sebti SM (2003) Farnesyltransferase inhibitors as anticancer agents: current status. Curr Opin Investig Drugs 4:1428-35 (Pubitemid 38120205)
31. Zimber C, Ben-Efraim S, Weiss DW (1982) Differential inhibition of contact sensitivity by suppressor T cells and suppressor factor induced by combined treatment with dinitrobenzenesulphonate and dinitro-fluorobenzene. Immunology 45:449-57 (Pubitemid 12165609)
32. Zundelevich A, Elad-Sfadia G, Haklai R et al. (2007) Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid). Mol Cancer Ther 6:1765-73 (Pubitemid 46954053)